+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Consumer Genomics Market Size, Share & Trends Analysis Report By Application (Genetic Relatedness, Diagnostics, Lifestyle, Wellness, & Nutrition, Ancestry), By Region, And Segment Forecasts, 2019 - 2025

  • ID: 4827932
  • Report
  • 150 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • 23andMe, Inc.
  • Ancestry
  • Diagnomics, Inc.
  • Helix OpCo LLC
  • Mapmygenome
  • Pathway Genomics
  • MORE
The global consumer genomics market size is projected to reach USD 4.63 billion by 2025 expanding at a CAGR of 20.3% during the forecast period, according to this report. Key factors driving the market include increasing awareness about implementing the genomic tests for the prediction of disease susceptibility and adoption of these tests as a personalized guide to fitness. Consumer genomic products are marketed through online websites that encourage customers to implement end-to-end solutions. These solutions can be applied for screening vulnerabilities of inherited diseases, person’s ancestry, carrier screening with just a swab of the saliva sample at their home settings.

The emergence of new consumer genomics market participants, such as Helix and Pathway Genomics, and the development of specific and user-friendly DTC tests lead to increased competition. Expanding scope of application of personalized medicine with the advancements in genetic technologies and single nucleotide polymorphism genotyping has paved the path for the treatment of complex diseases. Reducing costs of sequencing has made it possible to deliver genetic test analysis at affordable prices. Thus, the growing trend of DTC testing has evolved and is empowering the customers to have an in-depth analysis of their genomic data to assist them in making proactive health-related decisions.

Further key findings from the study suggest:
  • Advancements in the field of diagnostics supports the use of genomic data to extract the information about disease susceptibility, thereby fueling the consumer genomics market growth
  • Easy availability of maternal and paternal tests with minimal requirement of genetic counseling attributes to the dominant share of genetic relatedness
  • Growing awareness about non-invasive prenatal testing among drives the reproductive health application segment
  • Presence of key companies like AncestryDNA and 23andMe and number of ongoing genomics-related studies in U.S. contribute to the largest share of North America
  • Asia Pacific is expected to witness fastest CAGR from 2019 to 2025 owing to rising awareness about consumer genetic tests along with evolving genomic landscape in China
  • Companies in the global market include Ancestry, 23andMe, Inc., Helix OpCo LLC, Xcode Life, Diagnomics, Inc., Gene By Gene, Ltd. (FamilyTree DNA), Color Genomics, Positive Biosciences, Ltd., Futura Genetics, Mapmygenome, Pathway Genomics, MyHeritage Ltd., and Toolbox Genomics
  • These companies have undertaken several initiatives, such as the inclusion of pre- and post-genetic counseling for consumers

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 23andMe, Inc.
  • Ancestry
  • Diagnomics, Inc.
  • Helix OpCo LLC
  • Mapmygenome
  • Pathway Genomics
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased Database
2.1.2 Internal database
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity Flow & Bottom Up Approach
2.4.2 Approach 2: Top Down and Parent Market Analysis

Chapter 3 Consumer Genomics Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
3.1.1.2 Increase in access to DTC services due to reducing cost of genotyping
3.1.1.3 Expansion in applications of DTC genetics
3.1.1.3.1 Health testing
3.1.1.3.2 Ancestry
3.1.1.3.3 Genetic relatedness
3.1.1.4 Significant investments & initiatives by companies to maintain their competitive edge in the market
3.1.1.5 Growing trend of personalized genomics
3.1.2 Market restraint analysis
3.1.2.1 Ethical and clinical issues pertaining to the use of DTC products & personalized treatment
3.1.2.2 Misleading results create challenges in adoption of home-based genetic tests
3.1.2.3 Regulatory challenges pertaining to the use of DTC genetic tests
3.2 Penetration & Growth Prospect Mapping For Application, 2018
3.3 Global Consumer Genomics Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s

Chapter 4 Consumer Genomics Market Categorization: Application Estimates & Trend Analysis
4.1 Global Consumer Genomics Market: Application Movement Analysis
4.2 Genetic Relatedness
4.2.1 Global consumer genomics market for genetic relatedness, 2014 - 2025 (USD Million)
4.3 Diagnostics
4.3.1 Global consumer genomics market for diagnostics, 2014 - 2025 (USD Million)
4.4 Lifestyle, Wellness, & Nutrition
4.4.1 Global consumer genomics market for lifestyle, wellness, & nutrition, 2014 - 2025 (USD Million)
4.5 Ancestry
4.5.1 Global consumer genomics market for ancestry, 2014 - 2025 (USD Million)
4.6 Reproductive Health
4.6.1 Global consumer genomics market for reproductive health, 2014 - 2025 (USD Million)
4.7 Personalized Medicine & Pharmacogenetic Testing
4.7.1 Global consumer genomics market for personalized medicine & pharmacogenetic testing, 2014 - 2025 (USD Million)
4.8 Sports Nutrition & Health
4.8.1 Global consumer genomics market for sports nutrition & health, 2014 - 2025 (USD Million)
4.9 Others
4.9.1 Global consumer genomics market for others, 2014 - 2025 (USD Million)

Chapter 5 Consumer Genomics Market Categorization: Regional Estimates & Trend Analysis
5.1 Global Consumer Genomics Market Share By Regional, 2018 & 2025
5.2 Penetration & Growth Prospect Mapping For Region, 2018
5.3 North America
5.3.1 North America consumer genomics market, 2014 - 2025 (USD Million)
5.3.2 U.S.
5.3.2.1 U.S. consumer genomics market, by application, 2014 - 2025 (USD Million)
5.4 Canada
5.4.1.1 Canada consumer genomics market, by application, 2014 - 2025 (USD Million)
5.5 Europe
5.5.1 Europe consumer genomics market, 2014 - 2025 (USD Million)
5.5.2 Germany
5.5.2.1 Germany consumer genomics market, by application, 2014 - 2025 (USD Million)
5.5.3 U.K.
5.5.3.1 U.K. consumer genomics market, by application, 2014 - 2025 (USD Million)
5.6 Asia Pacific
5.6.1. Asia Pacific consumer genomics market, 2014 - 2025 (USD Million)
5.6.2 Japan
5.6.2.1 Japan consumer genomics market, by application, 2014 - 2025 (USD Million)
5.6.3 China
5.6.3.1 China consumer genomics market, by application, 2014 - 2025 (USD Million)
5.6.4 Australia
5.6.4.1 Australia consumer genomics market, by application, 2014 - 2025 (USD Million)
5.6.5 India
5.6.5.1 India consumer genomics market, by application, 2014 - 2025 (USD Million)
5.6.6 Singapore
5.6.6.1 Singapore consumer genomics market, by application, 2014 - 2025 (USD Million)
5.7 Latin America
5.7.1 Latin America consumer genomics market, by application, 2014 - 2025 (USD Million)
5.7.2 Brazil
5.7.2.1 Brazil consumer genomics market, by application, 2014 - 2025 (USD Million)
5.8 Middle East & Africa (MEA)
5.8.1 MEA consumer genomics market, 2014 - 2025 (USD Million)
5.8.2 South Africa
5.8.2.1 South Africa consumer genomics market, by application, 2014 - 2025 (USD Million)

Chapter 6 Consumer Genomics Market: Competitive Landscape
6.1 Strategy Framework
6.2 Market Participant Categorization
6.3 Company Profiles
6.3.1 Ancestry
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 23andMe, Inc.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Gene By Gene, Ltd. (FamilyTree DNA)
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Mapmygenome
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Color Genomics, Inc.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic Initiatives
6.3.6 Positive Biosciences, Ltd.
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Futura Genetics
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Helix OpCo LLC
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 MyHeritage Ltd.
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Pathway Genomics
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Veritas
6.3.11.1 Company overview
6.3.11.2 Financial performance
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 Myriad Genetics, Inc.
6.3.12.1 Company overview
6.3.12.2 Counsyl Inc.
6.3.12.2.1 Company overview
6.3.12.3 Financial performance
6.3.12.4 Product benchmarking
6.3.12.5 Strategic initiatives
6.3.13 Illumina, Inc.
6.3.13.1 Company overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives
6.3.14 Amgen, Inc.
6.3.14.1 Company overview
6.3.14.2 deCODE genetics
6.3.14.2.1 Company overview
6.3.14.3 Financial performance
6.3.14.4 Product benchmarking
6.3.14.5 Strategic initiatives
6.3.15 Xcode Life
6.3.15.1 Company overview
6.3.15.2 Financial performance
6.3.15.3 Product benchmarking
6.3.15.4 Strategic initiatives
6.3.16 Diagnomics, Inc.
6.3.16.1 Company overview
6.3.16.2 Financial performance
6.3.16.3 Product benchmarking
6.3.16.4 Strategic initiatives
6.3.17 Toolbox Genomics
6.3.17.1 Company overview
6.3.17.2 Financial performance
6.3.17.3 Product benchmarking
6.3.17.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Ancestry
  • 23andMe, Inc.
  • Gene By Gene, Ltd. (FamilyTree DNA)
  • Mapmygenome
  • Color Genomics, Inc.
  • Positive Biosciences, Ltd.
  • Futura Genetics
  • Helix OpCo LLC
  • MyHeritage Ltd.
  • Pathway Genomics
  • Veritas
  • yriad Genetics, Inc.
  • Illumina, Inc.
  • Amgen, Inc.
  • Xcode Life
  • Diagnomics, Inc.
  • Toolbox Genomics
Note: Product cover images may vary from those shown
Adroll
adroll